Found: 72
Select item for more details and to access through your institution.
Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower‐intensity therapy: Roadmap from an ELN‐DAVID expert panel.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 12, p. 1847, doi. 10.1002/ajh.27087
- By:
- Publication type:
- Article
Minimal residual disease as biomarker for optimal biologic dosing of ARA- C in patients with acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 2, p. 125, doi. 10.1002/ajh.23893
- By:
- Publication type:
- Article
Real-life experience with azacitidine in myelodysplastic syndromes according to IPSS cytogenetic profile.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 5, p. 565, doi. 10.1002/ajh.23677
- By:
- Publication type:
- Article
Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment.
- Published in:
- Life Science Alliance, 2022, v. 5, n. 12, p. 1, doi. 10.26508/lsa.202201590
- By:
- Publication type:
- Article
Pneumocystis jirovecii pneumonia in patients with previously untreated acute myeloid leukaemia.
- Published in:
- Mycoses, 2022, v. 65, n. 2, p. 233, doi. 10.1111/myc.13411
- By:
- Publication type:
- Article
Fever of Unknown Origin and Multidrug Resistant Organism Colonization in AML Patients.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2023, v. 15, n. 1, p. 1, doi. 10.4084/MJHID.2023.013
- By:
- Publication type:
- Article
Therapy-related Myeloid Neoplasms: Considerations for Patients' Clinical Evaluation.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2023, v. 15, n. 1, p. 1, doi. 10.4084/MJHID.2023.051
- By:
- Publication type:
- Article
The Venetoclax/Azacitidine Combination Targets the Disease Clone in Acute Myeloid Leukemia, Being Effective and Safe in a Patient with COVID-19.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2022, v. 14, n. 1, p. 1, doi. 10.4084/MJHID.2022.041
- By:
- Publication type:
- Article
Can Polycythemia Vera Evolve from Acute Myeloid Leukemia? Report of a Case Showing a Simultaneous Minor JAK2 V617F Mutated Clone.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2022, v. 14, n. 1, p. 1, doi. 10.4084/MJHID.2022.058
- By:
- Publication type:
- Article
Treatment of Acute Myeloid Leukemia with 20-30% Bone Marrow Blasts.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2013, v. 5, n. 1, p. 1, doi. 10.4084/MJHID.2013.032
- By:
- Publication type:
- Article
ESCCA/ISCCA protocol for the analysis of cerebrospinal fluid by multiparametric flow‐cytometry in hematological malignancies.
- Published in:
- Cytometry. Part B, 2021, v. 100, n. 3, p. 269, doi. 10.1002/cyto.b.21981
- By:
- Publication type:
- Article
The ISCCA flow protocol for the monitoring of anti‐CD20 therapies in autoimmune disorders.
- Published in:
- Cytometry. Part B, 2021, v. 100, n. 2, p. 194, doi. 10.1002/cyto.b.21930
- By:
- Publication type:
- Article
Automated Haematology Analysers in Acute and Chronic Leukaemias.
- Published in:
- Acta Haematologica, 1998, v. 100, n. 1, p. 61, doi. 10.1159/000040866
- By:
- Publication type:
- Article
Measurable Residual Disease (MRD) as a Surrogate Efficacy-Response Biomarker in AML.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 4, p. 3062, doi. 10.3390/ijms24043062
- By:
- Publication type:
- Article
Flow Cytometric Identification and Enumeration of Monocyte Subsets in Bovine and Water Buffalo Peripheral Blood.
- Published in:
- Current Protocols, 2023, v. 3, n. 2, p. 1, doi. 10.1002/cpz1.676
- By:
- Publication type:
- Article
Defining and Treating Older Adults with Acute Myeloid Leukemia who Are ineligible for intensive Therapies.
- Published in:
- Frontiers in Oncology, 2015, p. 1, doi. 10.3389/fonc.2015.00280
- By:
- Publication type:
- Article
The genotype nucleophosmin mutated and FLT3-ITD negative is characterized by high bax/bcl-2 ratio and favourable outcome in acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2010, v. 149, n. 3, p. 383, doi. 10.1111/j.1365-2141.2010.08098.x
- By:
- Publication type:
- Article
research paper CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemias.
- Published in:
- British Journal of Haematology, 2004, v. 125, n. 2, p. 203, doi. 10.1111/j.1365-2141.2004.04883.x
- By:
- Publication type:
- Article
P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2003, v. 121, n. 5, p. 730, doi. 10.1046/j.1365-2141.2003.04343.x
- By:
- Publication type:
- Article
Unlocking the potential of synthetic patients for accelerating clinical trials: Results of the first GIMEMA experience on acute myeloid leukemia patients.
- Published in:
- EJHaem, 2024, v. 5, n. 2, p. 353, doi. 10.1002/jha2.873
- By:
- Publication type:
- Article
Role of treatment on the development of secondary malignancies in patients with essential thrombocythemia.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 6, p. 1233, doi. 10.1002/cam4.1081
- By:
- Publication type:
- Article
Editorial: Measurable residual disease in hematologic malignancies.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1204393
- By:
- Publication type:
- Article
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia.
- Published in:
- European Journal of Haematology, 2016, v. 96, n. 4, p. 344, doi. 10.1111/ejh.12595
- By:
- Publication type:
- Article
Deferasirox chelation therapy in patients with transfusion-dependent MDS: a 'real-world' report from two regional Italian registries: Gruppo Romano Mielodisplasie and Registro Basilicata.
- Published in:
- European Journal of Haematology, 2015, v. 95, n. 1, p. 52, doi. 10.1111/ejh.12476
- By:
- Publication type:
- Article
Evaluation of the prognostic relevance ofl-selectin and ICAM1 expression in myelodysplastic syndromes.
- Published in:
- European Journal of Haematology, 2008, v. 80, n. 2, p. 107, doi. 10.1111/j.1600-0609.2007.00986.x
- By:
- Publication type:
- Article
Autologous stem-cell transplantation for patients with acute myeloid leukemia aged over 60 yr.
- Published in:
- European Journal of Haematology, 2002, v. 69, n. 4, p. 200, doi. 10.1034/j.1600-0609.2002.02806.x
- By:
- Publication type:
- Article
The Prognostic Significance of Measurable ('Minimal') Residual Disease in Acute Myeloid Leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 6, p. 547, doi. 10.1007/s11899-017-0420-z
- By:
- Publication type:
- Article
Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi‐centre setting.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 6, p. 891, doi. 10.1111/bjh.16594
- By:
- Publication type:
- Article
Genetic analysis of erythrocytosis reveals possible causative and modifier gene mutations.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 4, p. e100, doi. 10.1111/bjh.15931
- By:
- Publication type:
- Article
Mutational profile and haematological response to iron chelation in myelodysplastic syndromes (MDS).
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 5, p. 954, doi. 10.1111/bjh.15655
- By:
- Publication type:
- Article
Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 3, p. 361, doi. 10.1111/bjh.13138
- By:
- Publication type:
- Article
A cluster of Geotrichum clavatum ( Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature.
- Published in:
- Mycoses, 2016, v. 59, n. 9, p. 594, doi. 10.1111/myc.12508
- By:
- Publication type:
- Article
Azacitidine for the treatment of patients with acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 4, p. 1014, doi. 10.1002/cncr.26354
- By:
- Publication type:
- Article
Consolidation and Maintenance Immunotherapy With Rituximab Improve Clinical Outcome in Patients With B-cell Chronic Lymphocytic Leukemia.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 1, p. 119, doi. 10.1002/cncr.23144
- By:
- Publication type:
- Article
CD71<sup>-</sup> Alveolar Macrophages in Idiopathic Pulmonary Fibrosis: A Look beyond the Borders of the Disease.
- Published in:
- 2019
- By:
- Publication type:
- letter
Acute leukemia diagnosis during the COVID-19 pandemic.
- Published in:
- Panminerva Medica, 2023, v. 65, n. 1, p. 93, doi. 10.23736/S0031-0808.21.04618-8
- By:
- Publication type:
- Article
Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-90983-0
- By:
- Publication type:
- Article
MRD in AML: The Role of New Techniques.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00655
- By:
- Publication type:
- Article
FCγ Chimeric Receptor-engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance.
- Published in:
- Frontiers in Immunology, 2017, v. 8, p. 1, doi. 10.3389/fimmu.2017.00457
- By:
- Publication type:
- Article
Phase II Study of Bortezomib as a Single Agent in Patients with Previously Untreated or Relapsed/Refractory Acute Myeloid Leukemia Ineligible for Intensive Therapy.
- Published in:
- Leukemia Research & Treatment, 2013, p. 1, doi. 10.1155/2013/705714
- By:
- Publication type:
- Article
Signature of B-CLL with different prognosis by Shrunken centroids of surface antigen expression profiling.
- Published in:
- Journal of Cellular Physiology, 2005, v. 204, n. 1, p. 113, doi. 10.1002/jcp.20269
- By:
- Publication type:
- Article
Measurable Residual Disease and Clonal Evolution in Acute Myeloid Leukemia from Diagnosis to Post-Transplant Follow-Up: The Role of Next-Generation Sequencing.
- Published in:
- Biomedicines, 2023, v. 11, n. 2, p. 359, doi. 10.3390/biomedicines11020359
- By:
- Publication type:
- Article
Validation of the T-Lymphocyte Subset Index (TLSI) as a Score to Predict Mortality in Unvaccinated Hospitalized COVID-19 Patients.
- Published in:
- Biomedicines, 2022, v. 10, n. 11, p. 2788, doi. 10.3390/biomedicines10112788
- By:
- Publication type:
- Article
Case report: A Saprochaete clavata (Magnusiomyces clavatus) severe infection effectively treated with granulocyte transfusion in a young patient with myeloid sarcoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.970188
- By:
- Publication type:
- Article
Relapse Prevention in Acute Myeloid Leukemia: The Role of Immunotherapy with Histamine Dihydrochloride and Low-Dose Interleukin-2.
- Published in:
- Cancers, 2024, v. 16, n. 10, p. 1824, doi. 10.3390/cancers16101824
- By:
- Publication type:
- Article
Consensus for Flow Cytometry Clinical Report on Multiple Myeloma: A Multicenter Harmonization Process Merging Laboratory Experience and Clinical Needs.
- Published in:
- Cancers, 2023, v. 15, n. 7, p. 2060, doi. 10.3390/cancers15072060
- By:
- Publication type:
- Article
Time for Dynamic Assessment of Fitness in Acute Myeloid Leukemia.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Predictors of Early Thrombotic Events in Adult Patients with Acute Myeloid Leukemia: A Real-World Experience.
- Published in:
- Cancers, 2022, v. 14, n. 22, p. 5640, doi. 10.3390/cancers14225640
- By:
- Publication type:
- Article
Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 1083, doi. 10.3390/cancers13051083
- By:
- Publication type:
- Article
CD123 Is Consistently Expressed on NPM1 -Mutated AML Cells.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 496, doi. 10.3390/cancers13030496
- By:
- Publication type:
- Article